Improving treatment connections for hospitalized patients using opioids and methamphetamine
Patient Navigator plus Remote mHealth Adherence Support with Incentives to Improve Linkage and Retention among Hospitalized Patients with Opioid and Methamphetamine Use Who Initiate Buprenorphine
This study is looking to help people who use opioids and methamphetamine by making it easier for them to transition from the hospital to outpatient care, using a combination of personal support and mobile health tools to keep them engaged in their treatment after they leave the hospital.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10588501 on NIH RePORTER |
What this research studies
This research aims to enhance the transition from hospital to outpatient treatment for patients who use opioids and methamphetamine by combining patient navigation with mobile health (mHealth) support. The approach involves initiating buprenorphine treatment during hospitalization and providing ongoing support through financial incentives and personalized navigation to ensure patients stay connected to care after discharge. By focusing on the unique challenges faced by these patients, the study seeks to improve their treatment adherence and overall health outcomes. The intervention is guided by a behavioral model that emphasizes the importance of information, motivation, and skills in promoting positive health behaviors.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized patients who have a diagnosis of opioid use disorder and also use methamphetamine.
Not a fit: Patients who are not hospitalized or do not have a dual diagnosis of opioid and methamphetamine use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment retention and health outcomes for patients struggling with opioid and methamphetamine use.
How similar studies have performed: Previous research has shown the feasibility of initiating buprenorphine in hospitals, but this combined approach of patient navigation and mHealth support is novel and has not been extensively tested.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Tsui, Judith — University of Washington
- Study coordinator: Tsui, Judith
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.